The interaction between vascular endothelial cells (ECs) and cancer cells is of vital importance to understand tumor dissemination. A paradigmatic cancer to study cell-cell interactions is classical Hodgkin Lymphoma (cHL) owing to its complex microenvironment. The role of the interplay between cHL and ECs remains poorly understood. Here we identify canonical WNT pathway activity as important for the mutual interactions between cHL cells and ECs. We demonstrate that local canonical WNT signaling activates cHL cell chemotaxis toward ECs, adhesion to EC layers and cell invasion using not only the Wnt-inhibitor Dickkopf, tankyrases and casein kinase 1 inhibitors but also knockdown of the lymphocyte enhancer binding-factor 1 (LEF-1) and β-catenin in cHL cells. Furthermore, LEF-1-and β-catenin-regulated cHL secretome promoted EC migration, sprouting and vascular tube formation involving vascular endothelial growth factor A (VEGF-A). Importantly, high VEGFA expression is associated with a worse overall survival of cHL patients. These findings strongly support the concept that WNTs might function as a regulator of lymphoma dissemination by affecting cHL cell chemotaxis and promoting EC behavior and thus angiogenesis through paracrine interactions.
INTRODUCTION
Tumor microenvironment can initiate and promote cancer progression through its influences on tumor cell growth, metastasis and angiogenesis. 1 A paradigmatic cancer entity with a dominant microenvironment and highly complex tumor-stroma interactions is the classical Hodgkin lymphoma (cHL). 2 The malignant Hodgkin-Reed-Sternberg (HRS) cells account for o1% of the disease-related cells and highly depend on signaling crosstalk with their neighboring cells. Like no other tumor, cHL is dependent on paracrine interactions and thus perfectly serves as a model to study tumor-stroma interactions. 3 A fundamental characteristic of cancer progression is the tumor cell's ability to migrate and invade into surrounding tissues. Lymphoma cells are derived from the usually highly motile but strictly regulated immune cells and their dissemination capacity resembles physiological B-or T-cell migration capabilities, for example, during homing processes. 4 However, for germinal center-derived lymphoma such as cHLs, it is necessary to move out of the germinal center and through corresponding local endothelial cells (ECs) previous to dissemination to other lymph nodes or tissues. Thereby, another critical step for lymphocyte dissemination is the exit not only from the lymph but also from the bloodstream: This includes, for example, movements via high endothelial venules (HEVs), which present high levels of the chemokine with C-C motif, ligand 19 (CCL19) and CCL21 at their luminal faces. 5 Till et al. 6 have shown that chronic lymphoid lymphoma cells too migrate across HEVs into lymph nodes in response to CCL19 and CCL21. Although a function of chemokine (C-C motif) receptor 7 (CCR7) has been shown for HRS cell homing, the underlying cellular mechanisms have not been studied. 7 The question whether HRS cells, in turn, are able to induce tumor characteristics in ECs such as neoangiogenesis has not yet been sufficiently studied. Such a mutual interaction may promote lymphoma dissemination. First insights from the T-cellderived cHL cell line L540 showed that cHL might be capable to induce angiogenesis. 8 We hypothesize that chemokines or other chemoattractants might be exposed by ECs and thus guide HRS cells to metastatic niches. Furthermore, it is assumed that primary HRS cells are capable of creating gradients of motility-altering factors that attract and shape adjacent stromal and ECs.
Comparative analyses revealed differential migration preferences of cHL cells toward specific chemokines but lacked a detailed analysis of the underlying migratory mechanisms. 7 Moreover, studies on microenvironmental interactions focused on T-cells, macrophages, natural killer cells, mast cells, eosinophils, dendritic cells and fibroblasts. [9] [10] [11] Notably, studies highlighting cHL cell-EC interactions are missing, whereas for acute myeloic leukemia, prostate and breast cancer, evidence has been provided that the tumor cell-EC crosstalk influences carcinogenesis and tumor outcome. 12, 13 The mutual interactions between cHL cells and ECs are of fundamental interest but still remain to be studied.
The understanding of the capacity of HRS cells to promote EC behavior is also necessary to get insight into processes of lymphoma neoangiogenesis. During tumor angiogenesis, local ECs are switched from a resting to an active phenotype by an increase of proangiogenic regulators, such as vascular endothelial growth factors (VEGFs), fibroblast growth factors, angiopoietins or platelet-derived growth factor. Initial angiogenesis then involves the formation of tip cells at the leading front of new vascular sprouts. Next a lumen is formed and stabilization and maturation processes start.
14 As tumor cells create an imbalance of multiple angiogenesis regulators, tumor vessels are characterized by high leakiness, poor coverage with vascular supportive cells, reduced functionality (perfusion) and high remodeling potential. 15 WNT signaling is one pathway that is involved in different aspects of the above-mentioned processes such as metastasis and also regulation of angiogenesis. In different tumor entities, key components of canonical WNT signaling such as lymphocyte enhancer-binding factor-1 (LEF-1) are aberrantly expressed or, in case of β-catenin, the activity is deregulated. [16] [17] [18] [19] [20] Importantly, during physiological angiogenesis, WNT signaling has also been shown to be an important angiogenic regulator in the developing retina, placenta and ovaries. [21] [22] [23] In premalignant colonic epithelial neoplasias, canonical β-catenin-dependent WNT signaling has been shown to upregulate VEGF-A concomitant with angiogenesis. 24 Interestingly, canonical WNT signaling has not only been associated with angiogenesis but also with migration and metastasis in colorectal cancer, melanoma and lung adenocarcinoma. [25] [26] [27] Consequently targeting canonical WNT signaling, for example, by inhibition of the β-catenin destruction complex with either casein kinase 1 or tankyrases inhibitors might also be of therapeutic interest.
Our study provides evidence that locally active canonical WNT signaling is a regulator of chemokine-guided chemotaxis of cHL cells toward CCL19, involving the β-catenin and LEF-1 pathway. Supernatants of LEF-1 and β-catenin knockdown (KD) cells impaired EC migration, sprouting and tube formation owing to reduced secretion of VEGF-A by cHL cells. As LEF-1 expression can be observed in 33% of mixed-cellularity-type HL, and high VEGFA expression is associated with worse overall survival of cHL patients, our findings indicate that canonical WNT signaling has a critical role for the outcome in a subset of cHL.
MATERIALS AND METHODS

Cell lines and reagents
L428, L1236 and KM-H2 cell lines were obtained from Professor Volker Diehl (Cologne, Germany) and have been characterized previously. 28, 29 In constant intervals, we use a highly specific immunoglobulin (Ig) PCR to test for contaminations. In addition, L428 and L1236 cells have been tested very recently by STR profiling by the DSMZ (Braunschweig, Germany). Human umbilical vein endothelial cells (HUVECs) have been obtained from Lonza (Basel, Switzerland).
Proteins and small-molecule inhibitors included DKK1, DKK2 (both from R&D, Minneapolis, MN, USA), XAV-939 and PF670462 (both from Millipore, Billerica, MA, USA).
Primary antibodies were used against LEF-1 (2286), HDAC (2062) (both from Cell Signaling Technology, Danvers, USA), β-catenin (610153) (BD Biosciences, Franklin Lakes, NJ, USA), HSP90 (sc-13119) (Santa Cruz, Dallas, TX, USA), glyceraldehyde 3-phosphate dehydrogenase (ab8245) (Abcam, Cambridge, UK) and Tubulin (05-829, Millipore).
Secondary antibodies were goat IgG horseradish peroxidase-linked F(ab')2 fragment against mouse (sc 2005) or rabbit (sc-2004) (Santa Cruz).
Phycoerythrin-cyanine 7-conjugated mouse anti-human CCR7 (353226) and the corresponding isotype control (400232) (Biolegend, San Diego, CA, USA) were used for flow cytometry.
RNA-interference gene KD Small-interfering RNA (siRNA) against the indicated target genes or nonsense controls (scr, AM4611, Life Technologies, Carlsbad, CA, USA) were transfected into the cells using the Nucleofector 2b Device (Lonza) (Supplementary Methods).
Migration and invasion assays
For migration assays, the Boyden chamber with 8 μm porous membranes (Neuroprobe Inc., Gaithersburg, MD, USA) and, for chemotaxis assays, μ-Slide chemotaxis 3D chamber (Ibidi, Martinsried, Germany) with corresponding timelapse microscopy (Olympus IX81 with Olympus XM-10 camera; Olympus, Shinjuka, Japan) have been used (Supplementary Methods).
Angiogenesis assays
Angiogenesis assays, including HUVEC Scratch assay, sprouting assay and tube formation assay, can be found in Supplementary Methods.
Adhesion assay
Adhesion assays were performed as described by Zepeda-Moreno et al.
(Supplementary Methods).
Chick chorio-allantoic membrane (CAM) assay CAM assays were performed as previously described 31 (Supplementary Methods).
Additional methods can be found in Supplementary Methods.
RESULTS
Locally active canonical WNT signaling mediates CCL19-directed cHL cell chemotaxis Using the ex ovo chick CAM assay, the mutual interaction of lymphoma cells and their microenvironment can be studied. Spreading events of green fluorescent protein-expressing KM-H2 cells are observed within 72 h ( Figure 1a ). Therefore, after invading through the chorionic epithelium and establishing a primary localized tumor, lymphoma cells start to migrate not only through the stroma but also along existing vessels. This is indicative of direct interactions of lymphoma and ECs. Whether ECs guide this directed migration of the cHL cells or lymphoma cells reprogram vessel functions and what the underlying mechanisms are has not been clarified yet. The observed lymphoma growth includes processes such as invasiveness, migration and interactions with ECs, and of note, WNT signaling has previously been associated with these mechanisms in other malignancies. [25] [26] [27] We therefore studied the canonical WNT pathway and its influence on cHL cell chemotaxis as well as interactions with ECs. Very recently, we have provided evidence that, among other WNTs, WNT5A is specifically involved in these interactions. 32 Accordingly, different interventions of the canonical WNT signaling were studied in cHL cells in vitro first.
The migration of cHL cells toward CCL19 was analyzed using the modified Boyden chamber as described by Höpken et al. 7 First, the impact of Dickkopf-1 (DKK1) and DKK2, which inhibit the binding of WNTs to the co-receptors LRP5/6, was investigated. Each, DKK1 and DKK2, reduced CCL19-mediated cHL cell chemotaxis by 20%, and by 32% when used in combination (Figure 1b, Supplementary Figure S1A ). This strongly supports the view of a role of WNT signaling in cHL migration. Next inhibition of either casein kinase 1 or tankyrases as part of the β-catenin destruction complex was investigated. The inhibition of casein kinase 1 (PF670462) or tankyrases (XAV939) was associated with a reduction of cell chemotaxis rates by 45% and 24%, correspondingly ( Figure 1c, Supplementary Figure S1B Figure S4 ). This emphasizes that a basal canonical WNT pathway activity, which is important for cell motility, exists in cHL cells. Furthermore, enhanced nuclear β-catenin translocation could be observed after stimulation with conditioned medium (CM) of L428 and KM-H2 cells correspondingly, arguing that cHL cells secrete at least one canonical WNT that is able to sustain a basal canonical WNT signaling activity in cHL cells.
LEF-1 and β-catenin are required for cHL cell chemotaxis To further study the role of canonical WNT signaling during cHL cell chemotaxis, KD of β-catenin and LEF-1 were performed. (b) Migration of L428 and KM-H2 cells for 6 h after 24 h pretreatment with 100 ng/ml DKK1, DKK2 or DKK1 plus DKK2 was performed toward CCL19 in Boyden chamber assays (mean ± s.d., n = 3; two-way analysis of variance (ANOVA) and Bonferroni's post-hoc test, significance level is shown compared with respective PBS control, **P o0.01 and ***P o0.001). (c) Migration of L428 and KM-H2 cells for 6 h after 24 h pretreatment with 5 μM XAV939 or 0.05 μM PF670462 was performed toward CCL19 in Boyden chamber assays (mean ± s.d., XAV939, n = 4; PF670462, n = 3; two-way ANOVA and Bonferroni's post-hoc test, significance level is shown compared with respective dimethyl sulfoxide control, **Po 0.01 and ***P o0.001). (d) Western blotting of cytosolic and nuclear fractions of L428 cells stimulated for 24 or 48 h with CM or left untreated (ctrl). Note the increased nuclear β-catenin fraction after CM stimulation. As immunoblot controls, nuclear HDAC and cytosolic HSP90 amounts were determined to discriminate cytosolic and nuclear fractions. Relative β-catenin intensities compared with the respective cytosolic/nuclear controls are shown beneath (measured as area under the curve (AU) in percentage of the respective cytosolic or nuclear control).
The KD of both LEF-1 and β-catenin reduced cHL chemotaxis rates by approximately 30% without affecting cell doubling rates or CCR7 expression (Figures 2a and b, Supplementary Figures S5  and S6) . This is comparable with the decrease of cHL cell migration after intervention with DKK1/2, further supporting the hypothesis that canonical WNT pathway activity is important for cHL chemotaxis. The KD of LEF-1 and β-catenin further specifies the inhibition of cHL migration observed by inhibition of tankyrases and casein kinase 1. In addition, invasion through type-1 collagen was also significantly impaired by LEF-1 and β-catenin KD (Figure 2c ).
Nuclear LEF-1 is found in HRS cells in a subset of cHL patients Subsequently, the expression of LEF-1 was tested in patients. Importantly, publically available gene expression profiles show that expression of LEF-1 in cHL is almost as high as in chronic lymphatic leukemia or Burkitt lymphoma 33, 34 ( Figure 2d ). In addition, LEF-1 expression is increased in comparison to normal B-cells, including memory and germinal center B-cells (Figure 2e ). This argues for aberrant LEF-1 expression in cHL as it was observed in chronic lymphatic leukemia or Burkitt lymphoma. 17, 35, 36 As infiltrating T-cells may falsify LEF-1 gene expression data in cHL, we performed immunohistochemical analyses of LEF-1. A total of 27 cHL samples were stained, 18 of the nodularsclerosis type and 9 of the mixed-cellularity type. Nuclear LEF-1-positive HRS cells were found in 3/9 (33%) mixed-cellularity type and 1/18 (6%) nodular-sclerosis type. In Figure 2f , a mixedcellularity cHL with positive HRS cells and a corresponding case with LEF-1-negative HRS cells but positive bystander cells, most likely T-cells, are shown. Taken together, the in vitro investigations and the expression analyses of patient samples support the view that canonical WNT signaling is important for cell migration and invasion for a subgroup of cHL.
LEF-1 and β-catenin influence directionality and velocity of cHL cell migration The above used in vitro assays for migration and invasion measure only end points of complex and very dynamic motility processes. For further characterization, time-lapse studies of KM-H2 cells were performed (Supplementary Videos S1-S3). For that purpose, KM-H2 cells were analyzed in a three-dimensional (3D) collagen matrix. KM-H2 control (scr si) cells migrated in an amoeboid and highly directed manner along a CCL19 gradient (Figure 3a) . In contrast, the majority of LEF-1 and β-catenin KD cells had difficulties to orientate along the CCL19 gradient and to form protrusions. Therefore, LEF-1 and β-catenin are obviously important factors that regulate the directionality of cHL cell migration in a 3D collagen matrix. A further quantitative analysis of whole group movements revealed that cell velocities were significantly reduced from 1.1 to 0.6 and 0.4 μm/min after LEF-1 and β-catenin KD, respectively (Figure 3b) . Similarly, covered distances, including both the euclidean and accumulated distances, decreased strongly to approximately 30% and 50%, respectively, as compared with control KM-H2 cells (Figures 3c and d) . Next each cell track was converted into a biostatistical fingerprint as described previously to compare the track characteristics between LEF-1 and β-catenin KD cells. 32 Data are summarized as a similarity heat map (Supplementary Figure S7) . Tracks of the control (scr si) cells clearly separated from tracks of corresponding KD cells. By hierarchical clustering, the 15 most different movement classes were calculated and analyzed (Figure 3e ). One group of movement classes (1-7) was characterized by multiple short and few intermediate-sized intermediate steps. These paths were found in all the cell groups. Other classes were characterized by very short steps or even halts (classes 8-11). These classes predominantly represented the behavior of LEF-1 and β-catenin KD cells. The third group of cell migration paths is characterized by mostly straight and long single steps (classes [12] [13] [14] [15] . These classes are strikingly overrepresented in the control group. Of note, classes 8-11 displayed not continuous but always interrupted tracks. As these classes predominantly grouped with the LEF-1 and β-catenin KD cells, they are obviously characteristic for cells with defective canonical WNT signaling. This further supports our hypothesis that canonical WNT signaling is required for directed cell migration not only in 2D but also in 3D cell culture conditions. Canonical WNT signaling regulates the impact of cHL cells on EC migration, sprouting and tube formation Dissemination of HRS cells includes migration out of the germinal center but then HRS cells with metastatic potential exit the tumor lymph node via efferent lymph vessel or through HEVs and migrate predictably to the next functional node. As T-cell-derived L540 cHL cells may stimulate angiogenesis, it is of clinical interest to test the influence of HRS cell secretome on EC function and behavior in relation to canonical WNT signaling, to receive further insight into the regulatory molecular networks. 8 In modified Boyden chamber assays, supernatants of LEF-1 KD cHL cells were less potent in attracting HUVECs than corresponding control cells (Figure 4a , Supplementary Figure S8A ). Migration of ECs toward the supernatant of LEF-1 KD cHL cells was reduced to 50% compared with control cHL supernatant. This suggests that LEF-1 controls the cHL secretome and supports promigratory EC behavior. This was also supported in scratch assays, where HUVECs were directly incubated with the supernatant of LEF-1 KD cHL cells. Comparable to the analysis of HUVECs in Boyden chamber assays, migration rates were impaired (Figures 4b and c; Supplementary Figures S8B and C) . Therefore, the influence of the cHL cell secretome on EC migration is further underpinned. In conclusion, LEF-1 is not only an important and direct regulator of migration-associated pathways in cHL cells but also of secreted factors that act as chemoattractant for ECs.
To model initial sprouting of capillaries, a spheroid assay was applied. HUVEC spheroids incubated with CM of LEF-1-KD cHL cells sprouted only half as efficient as the controls (Figures 5a and b) . However, when sprouting events occurred, neither the number of sprouts nor their cumulative length differed between LEF-1 KD and control experiments (Figures 5c and d) . This suggests that LEF-1-regulated secreted factors from cHL cells are of importance for the initialization of EC sprouting rather than the morphological characteristics of the sprouts.
In the next steps of angiogenesis, capillaries elongate and a lumen is formed. This can partially be remodeled in vitro in the so-called tube-formation assays. Here we analyzed the influence of the secretome of cHL cells on the capacity of HUVECs to form branched, tube-like structures on extracellular matrix. Supernatants of cHL cells were capable of supporting tube formation of HUVECs (Figures 5e and f) , although less efficient than the complete growth factor-enriched EC medium. CM derived from LEF-1 and β-catenin KD cells showed a diminished capacity to support tube formation when compared with respective control CM. Therefore, our data reveal that secreted factors from cHL cells promote several separate steps of angiogenesis in ECs and this is dependent on the canonical WNT pathway components LEF-1 and β-catenin.
Finally, we studied direct interactions, which are relevant for tumor cell dissemination, and performed adhesion assays to investigate the capability of cHL cells to attach to ECs as well as type-1 collagen. This adhesion to ECs and to type-1 collagen was significantly impaired by the KD of LEF-1 in KM-H2 and L428 cells (Figure 5g, Supplementary Figure S8D) . Furthermore, LEF-1 regulated not only the migratory activity of HUVECs, as shown above, but also influenced their metabolic activity. This was significantly reduced after treatment with supernatant of LEF-1 KD cHL cells as revealed by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay (Supplementary Figures S8E and F) . Note the decrease of L428 cell migration after transient β-catenin KD (mean ± s.d., n = 3; unpaired, two-tailed t-test, **P o0.01). (c) Invasion of L428 and KM-H2 cells was measured through type-1 collagen-coated membranes toward CCL19 in Boyden chamber assays after 16 h. L428 and KM-H2 cells were transfected with LEF-1 or β-catenin siRNA 48 h prior to the invasion experiment. Note the decrease of invasion rates of LEF-1 and β-catenin KD cells (mean ± s.d., n = 3, one-way analysis of variance (ANOVA) and Bonferroni's post-hoc test, significance level is shown compared with respective scr si control, ***Po0.001). (d) LEF-1 expression data obtained by Basso et al. 33 were compared between cases of lymphoma/leukemia and subsets of untransformed physiological B-cells. Note the increased LEF-1 expression in analyzed lymphoma and leukemia cases (mean ± s.d., each n = 5 for B-lymphocytes, naive pre-germinal center B-lymphocytes, memory B-lymphocytes and centroblasts; Burkitt's Lymphoma, n = 31; Hodgkin lymphoma, n = 4 (cell lines); DLBCL, n = 41; chronic lymphatic leukemia, n = 34; one-way ANOVA and Bonferroni's post-hoc test). (e) LEF-1 expression data obtained by Brune et al. 34 were compared between cHL patient samples and subsets of untransformed physiological B-cells. Note the significantly higher LEF-1 expression in cHL patient samples (mean ± s.d., each n = 5 for naive pre-germinal center B-lymphocytes, memory B-lymphocytes, small cleaved follicle center B cells, centroblasts and plasma cells; Hodgkin lymphoma, n = 12 (patient material); one-way ANOVA and Bonferroni's post-hoc test, **Po 0.01 and ***P o0.001).
(f) Immunohistochemical staining of LEF-1-positive (left) and -negative (right) HRS cells of mixed-cellularity-type patients. HRS cells show nuclear LEF-1 staining only in the left case (inlet), whereas in some bystander cells also the nuclear LEF-1 staining can be observed.
Canonical WNT signaling regulates lymphoma formation and vascularization in CAM assays
As angiogenesis is a multi-step process, in vitro assays, which analyze isolated mechanisms, are of limited information. A wellestablished system to monitor the whole process of tumor angiogenesis, including vessel formation and destruction, is the CAM assay. As shown in Figure 1a , it is also a suitable system for cHL cells. Lymphomas produced from tankyrases inhibitor-treated KM-H2 cells were significantly smaller and showed less hemorrhages (Figures 6a-c) . Furthermore, in control tumors, bleeding was very prominent. Numerous microvessels branching from conducting vessels were present in the lymphoma and were obviously leaky (black arrows in Figure 6d , left). In contrast, vessel integrity was mostly preserved in tumors from XAV939-pretreated cHL cells (yellow arrows in Figure 6d, right) . In addition, we applied micro-CT techniques to virtually dissect the tumors and monitor vascular networks in the whole specimens. Dimethyl sulfoxide-treated control tumors contained numerous branched vessels and vessel residuals (arrows in Figure 6e , left). Vascular sprouts from preexisting CAM vessel penetrating into the lymphomas could be observed and support the view of cHL-mediated neoangiogenesis in this assay (Figure 6e, left) . One explanation might be that the cHL secretome affects ECs and new lymphoma-associated vessel formation taking into account the above described in vitro analysis. Importantly, the lymphomas derived from tankyrases inhibitor-pretreated cHL cells were hardly capable of forming such complex vascular networks in the tumor mass, thus underscoring the impact of canonical WNT signaling in cHL cells on ECs and vessel formation (Figure 6e, right) .
VEGF-A levels in cHL cell supernatant depend on LEF-1 and β-catenin, and VEGFA expression is predictive for cHL outcome As canonical WNT signaling in cHL had such a strong impact on EC behavior, we were interested in the underlying mechanisms. We speculated that the differential tumor biology may either be due to metabolic differences of the differently treated cHL cells themselves or to differences in the secretion of proangiogenic factors. To test the first hypothesis, nuclear magnetic resonance analyses of LEF-1 KD cells were performed (Supplementary Figure S9) . However, these data revealed no major differences in the content of metabolites, suggesting that the metabolic rates did not change significantly during the LEF-1 KD. The second hypothesis would suggest that LEF-1-KD cells secrete less proangiogenic factors than the control cells. One potent factor, which induces in vivo migration, sprouting and lumen formation of ECs, is VEGF-A. 37 Enzyme-linked immunosorbent assays of L428 and KM-H2 control supernatants reveal VEGF-A levels of 270 and 320 pg/ml per 10 5 cells, respectively (Figure 7a ). This amount of VEGF-A secreted by cHL cells was reduced not only by LEF-1 but also by β-catenin KD. The secreted VEGF-A levels dropped by Additional analyses of publically available patient microarray data revealed a significant correlation between VEGFA expression and the overall survival of cHL patients (Figure 7b) . 38 Although approximately 90% of patients with low VEGFA expression survived ⩾ 10 years, only 65% with high expression levels were alive after 10 years (P = 0.008). This indicates that aberrant LEF-1 expression and nuclear localization are observed in cHL cells. Importantly, VEGFA expression is directly correlated with patient's survival and therapy response. We therefore hypothesize that the regulation of VEGF-A secretion by LEF-1/β-catenin WNT signaling Canonical WNT signaling in Hodgkin lymphoma F Linke et al in vitro might also take place in vivo and contribute to VEGFA expression in patients.
DISCUSSION
The tumor microenvironment greatly influences tumorigenesis, which is very important in cHL. 2 The infiltration with immune cells provides essential survival signals for HRS cells and was central for recent investigations so far. 3, 39 However, mechanisms for dissemination of cHL cells, for example, along the vascular system or the interactions with the lymphoma endothelium, have rarely been studied. Here we describe mutual interactions between cHL cells and vascular ECs and provide compelling evidence that LEF-1 and β-catenin are of importance in these processes.
Our study highlights not only the role of canonical WNT pathway in regulating directed movement of the analyzed lymphoma cells and thus toward vascular niches mediated by chemokines likely presented by ECs but also that the attraction of ECs by cHL cells is regulated by WNT signaling. Therefore, we show mechanistically that canonical WNT signaling is a regulator of the mutual endothelium-lymphoma interplay. Our data support the view that cHL cells are able to migrate toward ECs in response to chemokines in a LEF-1-and β-catenin-dependent manner and also attract ECs most likely via VEGF-A secretion. Importantly, for both processes canonical WNT signaling of lymphoma cells is a prerequisite.
Blocking canonical WNT signaling of cHL cells at different levels of the pathway resulted in reduced chemotactic migration and invasion. Interestingly, the LEF-1 or β-catenin influence was even more obvious in 3D migration assays with type-1 collagen. From these studies, the hypothesis can be deduced for future studies that there is a specific role for collagen-mediated canonical WNT signaling in cHL cell movements. This hypothesis has to take into account the recent observation about the DDR1 and DDR2 signaling pathway. 40, 41 However, future studies will have to investigate whether the interaction of cHL cells with collagen is regulating WNT-mediated lymphoma cell motility or whether the canonical WNT pathway is a prerequisite for collagen-mediated chemotaxis.
The migration and adhesion of lymphoma cells to HUVECs is a model to study the dissemination process of the tumor cells and may have a major impact on the understanding of the outcome of the disease. Although not investigated for cHL, the adherence to HEVs has been associated with the dissemination potential of nonHodgkin lymphomas, which has been confirmed in lymphoma mouse models. 42, 43 Therefore, endothelium-mediated chemotaxis and adherence of lymphoma cells to ECs can be regarded as an important parameter for cHL progression. Given this, the question rises whether cHL cells gain an additional benefit from their proximity to ECs, despite the apparent induction of angiogenesis and facilitation of dissemination. One important observation by Fhu et al. 44 was that cHL cells actively secrete lymphotoxin-α, which caused the upregulation of adhesion molecules in ECs, thereby recruiting CD4 + naive T-cells. This suggests that ECs can actively participate in the recruitment of lymphoma-supporting T-cells and shape the cHL microenvironment toward a protumorigenic niche. The secretion of VEGF-A by cHL cells fits into this scenario of an active cHL-EC interaction. But our data also show that additionally separate functions for ECs in cHL progression exist.
In a previous study, 70.6% (41/61) of immunostained cHL samples were positive for VEGF-A. 45 Our re-evaluation of the published patient's data shows that high VEGFA gene expression correlates with a significantly worse overall survival. 38 These results are consistent with previous findings on the importance of neovascularization and proangiogenic factors in cHL cases. [46] [47] [48] [49] Nevertheless, VEGF-A might not only be secreted by cHL cells but also by cells of the lymphoma microenvironment. Tumorassociated macrophages have been shown as involved in different aspects of angiogenesis regulation. 50 In the present study, we provide evidence for WNT-regulated signaling mechanisms of VEGF-A secretion in cHL. Recently, a proangiogenic potential of the T-cell-derived L540 cHL cell line has been shown using 1% serum cell culture conditions. 8 We cannot exclude that in our experiments remnants of serum in the CM may have led to an overestimation of the proangiogenic potential of B-cell-derived cHL cells. However, the study of WNT functions requires higher serum concentrations to avoid precipitation of WNT proteins. Nevertheless, by comparing LEF-1 KD and control cells we have clearly shown an involvement of LEF-1 in angiogenic processes. This further supports the view about the angiogenic potential of B-cell-derived cHL cells. As proposed by Marinaccio et al., 51 we were able to evaluate the proangiogenic potential of cHL cells in CAM assays in vivo and demonstrated that canonical WNT signaling has an impact on angiogenesis.
Our experimental data provide compelling evidence that for cHL cells basal (constitutively) active canonical WNT signaling is required to attract ECs and to enhance their migration, sprouting and tube formation capacities. We identified VEGF-A as a factor secreted in a LEF-1-and β-catenin-dependent manner. Nevertheless, it can be assumed that the secretion of other angiogenesis modulating factors such as fibroblast growth factor might be regulated by canonical WNT signaling in cHL cells. To assess the complete effects of LEF-1 and β-catenin signaling in cHL, a comprehensive secretome analysis shall be performed in future experiments. In addition, the LEF-1-and β-catenin-mediated WNT signaling might be part of a so far unrevealed network affecting VEGF-A secretion and thus influence ECs in general. Other pathways that are well known for their contribution to cHL pathogenesis might also be involved and have to be investigated for their impact on EC behavior in the future.
In summary, our results show that canonical WNT signaling significantly affects cHL cell chemotaxis and secreted VEGF-A levels, leading to remarkable prolymphomagenic effects in vitro and in vivo. Therefore, larger clinical trials with anti-VEGF-A drugs targeting the interplay of cHL cells and ECs, and probably complemented with WNT inhibitors, will be needed to evaluate the impact of canonical WNT signaling and the cHL-endothelial interaction as therapeutic targets. Figure 7 . VEGF-A secretion of cHL cells is reduced by LEF-1/β-catenin and high VEGFA gene expression is associated with a worse clinical outcome in cHL patients. (a) VEGF-A levels of scr si control, LEF-1 si and β-catenin si L428 and KM-H2 cell supernatants from three independent nucleofections were measured using enzyme-linked immunosorbent assay and normalized to the 10 5 cells per ml. Note the decreased VEGF-A levels after LEF-1 and β-catenin KD (mean ± s.d., n = 3). (b) VEGFA expression data obtained by Steidl et al. 38 was correlated with the overall survival of cHL patients. High VEGFA gene expression is associated with a significant shorter overall survival for cHL patients (mean ± s.d., low, n = 56; high, n = 68; Log-rank Mantel-Cox test, **P o0.01). 
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